[Co-payment on prescription drugs in the Spanish public health system: Certainty, risk and selection of risks].
The model of co-payment on prescription drugs in the Spanish National Health System (NHS) changed on 1 July 2012. For more than three decades that it was not modified. This article provides a brief historical reminder of the evolution of this model of co-payment. The basic characteristics of this model are compared with the model of copayment on prescription drugs of the Administrative Mutualism (Civil Servants). The document provides detailed information on the percentage of effective copayment, fundraising effects, the economic participation of the patient, among others, in both models. Finally, listed pending improvements not addressed by 2012 changes such as the concentration of the co-payment in the active patient population and risk selection promoted by the differences in the financial contribution between the two models of co-payment (NHS and Mutualist).
Medicina de Familia, Centro de Salud de Rochapea, Pamplona, Navarra, España. Electronic address: ju.simom@gmail.com.
Juan
J
Simó Miñana
D017047:Cost Sharing; D006801:Humans; D055553:Prescription Drugs / Q000191:economics*; D011634:Public Health; D013030:Spain; D013222:State Medicine
D055553:Prescription Drugs
Atención sanitaria; Drug prescription/economics; Health care; Justicia social; Medicamentos de prescripción/economía; Social justice